160 related articles for article (PubMed ID: 32042082)
1. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
Leukemia; 2020 Aug; 34(8):2262-2264. PubMed ID: 32042082
[No Abstract] [Full Text] [Related]
2. Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F; Bidet A; Veronese L; Daudignon A; Penther D; Troadec MB; Lefebvre C; Lafage-Pochitaloff M
Leukemia; 2020 Jun; 34(6):1711-1713. PubMed ID: 31862958
[No Abstract] [Full Text] [Related]
3. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
[TBL] [Abstract][Full Text] [Related]
4. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F; Bidet A; Daudignon A; Lafage-Pochitaloff M; Ameye G; Bilhou-Nabéra C; Chapiro E; Collonge-Rame MA; Cuccuini W; Douet-Guilbert N; Eclache V; Luquet I; Michaux L; Nadal N; Penther D; Quilichini B; Terre C; Lefebvre C; Troadec MB; Véronèse L
Leukemia; 2022 Jun; 36(6):1451-1466. PubMed ID: 35430613
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Daudignon A; Quilichini B; Ameye G; Poirel H; Bastard C; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):588-595. PubMed ID: 27707673
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique.
Nguyen-Khac F; Bidet A; Chapiro E; Lefebvre C; Michaux L; Troadec MB
Curr Res Transl Med; 2023; 71(4):103411. PubMed ID: 37984195
[No Abstract] [Full Text] [Related]
10. Cytogenetics in the management of children and adult acute lymphoblastic leukemia (ALL): an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Baranger L; Cuccuini W; Lefebvre C; Luquet I; Perot C; Radford I; Lafage-Pochitaloff M
Ann Biol Clin (Paris); 2016 Oct; 74(5):547-560. PubMed ID: 27707671
[TBL] [Abstract][Full Text] [Related]
11. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.
Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
Leukemia; 2019 Aug; 33(8):1851-1867. PubMed ID: 30696948
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Borie C; Callet-Bauchu E; Eclache V; Struski S
Ann Biol Clin (Paris); 2016 Oct; 74(5):561-567. PubMed ID: 27628190
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
16. Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
Larson DP; Akkari YM; Van Dyke DL; Raca G; Gardner JA; Rehder CW; Kaiser-Rogers KA; Eagle P; Yuhas JA; Gu J; Toydemir RM; Kearney H; Conlin LK; Tang G; Dolan MM; Ketterling RP; Peterson JF
Arch Pathol Lab Med; 2021 Feb; 145(2):176-190. PubMed ID: 32886736
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of a double agent: cytogenetics in hematology].
Berger R
Pathol Biol (Paris); 2003 Aug; 51(6):305-6. PubMed ID: 12927886
[No Abstract] [Full Text] [Related]
18. The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Bidet A; Troadec MB; Veronese L; Auger N; Daudignon A; Nadal N; Penther D; Michaux L; Lafage-Pochitaloff M; Lefebvre C
Leukemia; 2023 Apr; 37(4):946-947. PubMed ID: 36707618
[No Abstract] [Full Text] [Related]
19. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
[No Abstract] [Full Text] [Related]
20. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
Maciejewski JP; Tiu RV; O'Keefe C
Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]